Page last updated: 2024-08-21

indazoles and Leukoencephalopathy Syndrome, Posterior

indazoles has been researched along with Leukoencephalopathy Syndrome, Posterior in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (87.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Houchi, H; Kawakita, K; Kosaka, S; Kuroda, Y; Okazaki, T; Suzuki, K; Takahashi, K; Tanaka, H; Tatsumichi, T	1
Fehnel, CR; Miller-Patterson, C	1
Deguchi, S; Endo, M; Hayashi, N; Katagiri, H; Mitsuya, K; Murata, H; Nakasu, Y; Takahashi, M; Wasa, J	1
Arslan, BM; Bajrami, A; Cabalar, M; Demir, E; Yayla, V	1
Albiges, L; Ammari, S; Benmoussa, L; Escudier, B; Levy, A	1
Maltezou, M; Miaris, N; Papaxoinis, G; Samantas, E; Visvikis, A	1
Amarantidis, K; Chamalidou, E; Chelis, L; Christakidis, E; Dimopoulos, P; Kakolyris, S; Michailidis, P; Prassopoulos, P; Souftas, V; Xenidis, N	1
Asaithambi, G; Hurliman, E; Khan, AS; Moran, BP; Peters, BR; Taylor, RA	1

Reviews

2 review(s) available for indazoles and Leukoencephalopathy Syndrome, Posterior

Article	Year
Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature. Investigational new drugs, 2018, Volume: 36, Issue:2 Topics: Brain; Fatal Outcome; Female; Humans; Indazoles; Magnetic Resonance Imaging; Middle Aged; Posterior Leukoencephalopathy Syndrome; Protein Kinase Inhibitors; Pyrimidines; Sarcoma; Sulfonamides	2018
Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Axitinib; Carcinoma, Renal Cell; Everolimus; Fatal Outcome; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Magnetic Resonance Imaging; Middle Aged; Nephrotic Syndrome; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides	2017

Article

Year

Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.

Investigational new drugs, 2018, Volume: 36, Issue:2

Topics: Brain; Fatal Outcome; Female; Humans; Indazoles; Magnetic Resonance Imaging; Middle Aged; Posterior Leukoencephalopathy Syndrome; Protein Kinase Inhibitors; Pyrimidines; Sarcoma; Sulfonamides

2018

Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature.

Clinical genitourinary cancer, 2017, Volume: 15, Issue:1

Topics: Axitinib; Carcinoma, Renal Cell; Everolimus; Fatal Outcome; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Magnetic Resonance Imaging; Middle Aged; Nephrotic Syndrome; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides

2017

Other Studies

6 other study(ies) available for indazoles and Leukoencephalopathy Syndrome, Posterior

Article	Year
Uterine sarcoma with posterior reversible encephalopathy syndrome associated with pazopanib. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:1 Topics: Angiogenesis Inhibitors; Diagnosis, Differential; Female; Humans; Indazoles; Magnetic Resonance Imaging; Middle Aged; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sarcoma; Sulfonamides; Uterine Neoplasms	2021
Pazopanib-associated posterior reversible encephalopathy syndrome with intracerebral haemorrhage. BMJ case reports, 2017, Apr-17, Volume: 2017 Topics: Aged; Carcinoma, Renal Cell; Cerebral Hemorrhage; Decompressive Craniectomy; Female; Humans; Indazoles; Kidney Neoplasms; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides; Treatment Outcome	2017
Pazopanib induced unilateral posterior reversible encephalopathy syndrome. Ideggyogyaszati szemle, 2017, Mar-30, Volume: 70, Issue:3-4 Topics: Adult; Angiogenesis Inhibitors; Humans; Indazoles; Male; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides; Testicular Neoplasms	2017
Reversible posterior leukoencephalopathy syndrome induced by axitinib. Clinical genitourinary cancer, 2014, Volume: 12, Issue:1 Topics: Axitinib; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Middle Aged; Posterior Leukoencephalopathy Syndrome; Protein Kinase Inhibitors; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor	2014
Reversible posterior leukoencephalopathy syndrome induced by pazopanib. BMC cancer, 2012, Oct-22, Volume: 12 Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indazoles; Kidney Neoplasms; Neoplasm Metastasis; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides	2012
Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma. Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:2 Topics: Aged; Carcinoma, Renal Cell; Humans; Immunosuppressive Agents; Indazoles; Kidney Neoplasms; Male; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides; Vascular Endothelial Growth Factor A	2013